Module 7 - Cardiac Pharmacology Flashcards
Medication Access
Drugs typically require 1 to 2 minutes to reach the central circulation when given to peripheral access.
Resuscitation drugs are usually administered by bolus injection, followed by a 20 mL bolus of IV fluid.
The intraosseous (IO) route maybe used if IV access isn’t available, with endotracheal administration being another alternative.
Endotracheal administration results in lower blood concentrations of the same dose given intravascularly
Resuscitation
Resuscitation guidelines are evidence – based recommendations. This means that international resuscitation experts meet to evaluate published research and new conclusions in the form of recommendations.
Drugs should be given during CPR as soon as possible after the rhythm is checked. Drug delivery should not interrupt CPR.
What are the two categories of ACLS drugs?
Medications for cardiovascular support:
These are sometimes called pharmacology I category drugs; they alter cardiac output, rate, and peripheral vascular resistance.
Medications for arrest rhythms:
These medications control rate and rhythms.
Name 10 medications for cardiovascular support (pharmacology I category drugs)
Epinephrine Vasopressin Norepinephrine Dobutamine Dopamine Digoxin Inamrinome Milrinone Nitroglycerin Sodium nitroprusside
What are the effects of Epinephrine (pharmacology I category drug) when used for cardiovascular support?
Inotropic/vasopressor
What are the effects of Vasopressin (pharmacology I category drug) when used for cardiovascular support?
Non-adrenergic peripheral, coronary, and renal vasoconstrictor
What are the effects of Norepinephrine (pharmacology I category drug) when used for cardiovascular support?
Inotrope/vasoconstrictor
What are the effects of Dopamine (pharmacology I category drug) when used for cardiovascular support?
Adrenergic agonist/dopamine agonist
What are the effects of Dobutamine (pharmacology I category drug) when used for cardiovascular support?
Inotrope
What are the effects of Nitroglycerin (pharmacology I category drug) when used for cardiovascular support?
Vasodilator
What are the effects of Digoxin (pharmacology I category drug) when used for cardiovascular support?
Inotrope/ventricular rate control
Indications:
digoxin is used in advanced cardiac life support (ACLS) to slow ventricular response in atrial fibrillation or atrial flutter.
Precautions:
Digoxin toxicity is frequently associated with serious arrhythmias.
What are the 3 Specific Pharmacology Agents?
Oxygen: provide 100% O2
Key component in resuscitating and emergency cardiac care.
Used for all patients with acute chest pain due to cardiac ischemia, hypoxemia, and cardiac arrest.
Dosage:
You can provide 22% to 100% FIO2 through positive – pressure ventilation or with a manual resuscitator bag.
Precautions:
Problems with oxygen depend on the concentration and the duration of exposure.
Describe what epinephrine is and does
Natural Catecholamine (naturally occurs the human body) with both alpha and beta effects. Causes peripheral vasoconstriction, leading to improved myocardial and cerebral perfusion to vital organs. Increases BP and the rate and force of contraction.
What dosage of epinephrine should be used during a code?
Dosage:
Standard dose is 1 mg given intravenously every 3 to 5 minutes
Precautions:
Should not be mixed with alkaline solutions such as bicarb (HCO3).
If given in patients who are not in cardiac arrest, could result in hypertension.
What is Vasopressin?
Vasopressin is a naturally occurring antidiuretic hormone (ADH)
In high doses, it acts as a noradrenergic peripheral, coronary, and renal vasoconstrictor.
Indications:
Vasopressin could be considered as an alternative to either the first or second dose of epinephrine and treatment of pulseless arrest. It may be effective in patients with asystole or pulseless electrical activity and in patients who remain in cardiac arrest after treatment with epinephrine.
Dosage:
Single – dose vasopressin is given one time only has 40 units IV/IO.
Precautions: the current evidence for the use of the suppressant in cardiac arrest is promising, but it’s use hasn’t improved the rate of intact survival to hospital discharge.